Holdings of Merck & Co., Inc.
10 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 100 % of the equity sleeve
Sector breakdown
- Health care 37.1 %
- Unattributed 62.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 10 | 316.1M $ | 100.00 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Moderna Inc | 2,308,190 | 117.3M $ | |
| Personalis Inc | 14,044,943 | 89.5M $ | |
| Kymera Therapeutics Inc | 772,165 | 64.3M $ | |
| Eikon Therapeutics Inc | 1,666,666 | 17.6M $ | |
| Aktis Oncology Inc | 952,844 | 17M $ | |
| Alector Inc | 3,545,719 | 7.6M $ | |
| Viridian Therapeutics Inc | 93,414 | 1.8M $ | |
| Xilio Therapeutics Inc | 105,982 | 891.3K $ | |
| NEUPHORIA THERAPEUTICS INC | 10,027 | 40.8K $ | |
| TuHURA Biosciences Inc | 19,445 | 34.8K $ |